Colin Nixon

Colin Nixon (born 8 September 1978) is a retired footballer from Northern Ireland who was the technical director of Glentoran Academy. Son of Alice and Hugh Nixon, Colin has a large football related family and has three children. Provided by Wikipedia
Showing 1 - 5 results of 5 for search 'Colin Nixon', query time: 0.02s Refine Results
  1. 1
    Positron emission tomography imaging of the sodium iodide symporter senses real-time energy stress in vivo

    Positron emission tomography imaging of the sodium iodide symporter senses real-time energy stress in vivo by Piotr Dzien, Agata Mackintosh, Gaurav Malviya, Emma Johnson, Dmitry Soloviev, Gavin Brown, Alejandro Huerta Uribe, Colin Nixon, Scott K. Lyons, Oliver Maddocks, Karen Blyth, David Y. Lewis

    Published 2023-09-01
    Get full text
    Article
  2. 2
    NUAK1 governs centrosome replication in pancreatic cancer via MYPT1/PP1β and GSK3β‐dependent regulation of PLK4

    NUAK1 governs centrosome replication in pancreatic cancer via MYPT1/PP1β and GSK3β‐dependent regulation of PLK4 by Declan Whyte, George Skalka, Peter Walsh, Ania Wilczynska, Nikki R. Paul, Claire Mitchell, Colin Nixon, William Clarke, Martin Bushell, Jennifer P. Morton, Daniel J. Murphy, Nathiya Muthalagu

    Published 2023-07-01
    Get full text
    Article
  3. 3
    KRAS allelic imbalance drives tumour initiation yet suppresses metastasis in colorectal cancer in vivo

    KRAS allelic imbalance drives tumour initiation yet suppresses metastasis in colorectal cancer in vivo by Arafath K. Najumudeen, Sigrid K. Fey, Laura M. Millett, Catriona A. Ford, Kathryn Gilroy, Nuray Gunduz, Rachel A. Ridgway, Eve Anderson, Douglas Strathdee, William Clark, Colin Nixon, Jennifer P. Morton, Andrew D. Campbell, Owen J. Sansom

    Published 2024-01-01
    Get full text
    Article
  4. 4
    THEM6‐mediated reprogramming of lipid metabolism supports treatment resistance in prostate cancer

    THEM6‐mediated reprogramming of lipid metabolism supports treatment resistance in prostate cancer by Arnaud Blomme, Coralie Peter, Ernest Mui, Giovanny Rodriguez Blanco, Ning An, Louise M Mason, Lauren E Jamieson, Grace H McGregor, Sergio Lilla, Chara Ntala, Rachana Patel, Marc Thiry, Sonia H Y Kung, Marine Leclercq, Catriona A Ford, Linda K Rushworth, David J McGarry, Susan Mason, Peter Repiscak, Colin Nixon, Mark J Salji, Elke Markert, Gillian M MacKay, Jurre J Kamphorst, Duncan Graham, Karen Faulds, Ladan Fazli, Martin E Gleave, Edward Avezov, Joanne Edwards, Huabing Yin, David Sumpton, Karen Blyth, Pierre Close, Daniel J Murphy, Sara Zanivan, Hing Y Leung

    Published 2022-03-01
    Get full text
    Article
  5. 5
    JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors

    JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors by Kathryn A. F. Pennel, Phimmada Hatthakarnkul, Colin S. Wood, Guang-Yu Lian, Sara S. F. Al-Badran, Jean A. Quinn, Assya Legrini, Jitwadee Inthagard, Peter G. Alexander, Hester van Wyk, Ahmad Kurniawan, Umar Hashmi, Michael A. Gillespie, Megan Mills, Aula Ammar, Jennifer Hay, Ditte Andersen, Colin Nixon, Selma Rebus, David K. Chang, Caroline Kelly, Andrea Harkin, Janet Graham, David Church, Ian Tomlinson, Mark Saunders, Tim Iveson, Tamsin R. M. Lannagan, Rene Jackstadt, Noori Maka, Paul G. Horgan, Campbell S. D. Roxburgh, Owen J. Sansom, Donald C. McMillan, Colin W. Steele, Nigel B. Jamieson, James H. Park, Antonia K. Roseweir, Joanne Edwards

    Published 2024-03-01
    Get full text
    Article

Search Tools: